研究成果

[雑誌論文] Retrospective Analysis of Autologous Stem Cell Transplantation for AL Amyloidosis: A Study from the Multiple Myeloma Working Group of the Japan Society for Hematopoietic Cell Transplantation

Fuchida Shin-ichi、Kawamura Koji、Sunami Kazutaka、Tsukada Nobuhiro、Fujii Shiro、Ohkawara Hiroshi、Usuki Kensuke、Wake Atsushi、Endo Shinya、Ishiyama Ken、Ueda Yasunori、Nakamura Yukinori、Miyamoto Toshihiro、Fukuda Takahiro、Ichinohe Tatsuo、Atsuta Yoshiko、Takamatsu Hiroyuki 2022

[学会発表] 肝臓アミロイドーシスに対する超音波エラストグラフィを用いた非侵襲的診断法の有用性.

三木浩和, 中村信元, 中村昌史, 住谷龍平, 大浦雅博, 曽我部公子, 髙橋 真美子, 丸橋朋子, 原田武志, 藤井志朗, 西尾進, 友成哲, 安倍正博 2022

[学会発表] 形質細胞疾患における新型コロナワクチンの有効性

中村信元, 堀太貴, 中村昌史, 住谷龍平, 大浦雅博, 曽我部公子, 丸橋朋子, 髙橋真美子, 藤井志朗, 三木浩和, 原田武志, 安倍正博 2022

[学会発表] RNA編集酵素ADAR1を標的にする1q増幅骨髄腫細胞に対する治療法の開発

原田武志, 住谷龍平, 小田明日香, 井上雄介, 大浦雅博, 曽我部公子, 丸橋朋子, 高橋真美子, 藤井志朗, 中村信元, 三木浩和, 天眞寛文, 日浅雅博, 寺町順平, 安倍正博 2022

[学会発表] 骨髄腫細胞のプロテアソーム阻害薬への抵抗性の機序と温熱療法によるその克服の可能性

丸橋 朋子, 三木 浩和, 曽我部 公子, 原田 武志, 小田 明日香, 中村 信元, 中村 昌史,住谷 龍平, 大浦 雅博, 高橋 真美子, 藤井志朗, 安倍 正博 2022

[学会発表] Local hyperthermia against extramedullary plasmacytomas: cooperation with proteasome inhibitors.

Tomoko Maruhashi, Hirokazu Miki, Kimiko Sogabe, Asuka Oda, Masafumi Nakamura, Ryohei Sumitani, Masahiro Oura, Mamiko Takahashi, Takeshi Harada, Shiro Fujii, Shingen Nakamura, Masahiro Abe 2022

[学会発表] TAK1 阻害は骨髄腫の細胞間相互作用による骨破壊と薬剤耐性を改善する

寺町順平, 天真寛文, 日浅雅博, 小田明日香, 清水宗, 住谷龍平, 大浦雅博, 曽我部公子, 丸橋朋子, 藤井志朗, 中村信元, 三木浩和, 遠藤逸朗, 原田　武志, 安倍正博 2022

[学会発表] 骨髄腫に対する抗体免疫療法へのTh1様γδT細胞の応用

井上雄介, 原田武志, 天眞寛文, 小田明日香, 住谷龍平, 大浦雅博, 曽我部公子, 丸橋朋子, 高橋真美子, 藤井志朗, 中村信元, 三木浩和, 日浅雅博, 寺町順平, 安倍正博 2022

[学会発表] The importance of retaining physical functions to prevent SRE in multiple myeloma.

Hirokazu Miki, Shingen Nakamura, Masafumi Nakamura, Makiko Mizuguchi, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Mamiko Takahashi, Tomoko Maruhashi, Takeshi Harada, Shiro Fujii, Kumiko Kagawa, Hirofumi Hamano, Masateru Kondo, Naoto Okada, Yoshimi Bando, Itsuro Endo, Masahiro Abe 2021

[学会発表] Diagnostic efficacy of non-invasive ultrasound shear wave elastography for hepatic AL amyloidosis.

Hirokazu Miki, Shingen Nakamura, Shiro Fujii, Masafumi Nakamura, Makiko Mizuguchi, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Mamiko Takahashi, Tomoko Maruhashi, Takeshi Harada, Kumiko Kagawa, Susumu Nishio, Tetsu Tomonari, Masahiro Abe 2021

[学会発表] Down-regulation of the IRF4-SLAMF7 axis in MM cells by CELMoDs and HDAC inhibition.

Yusuke Inoue, Takeshi Harada, Hirofumi Tenshin, Asuka Oda, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe 2021

[学会発表] Induction of elotuzumab’s ADCC activity by Th1-like γδ T cells towards osteoclasts as well as myeloma cells.

Takeshi Harada, Yusuke Inoue, Hirofumi Tenshin, Asuka Oda, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe 2021

[学会発表] Mechanisms for the resistance to proteasome inhibitors in myeloma cells: the role of PIM2 and Akt kinase activation and NRF2 accumulation

Kimiko Sogabe Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Asuka Oda, Yusuke Inoue, Ryohei Sumitani, Masahiro Oura, Shiro Fujii, Kumiko Kagawa, Hirofumi Tenshin, Jumpei Teramachi, Masaki Ri, Shinsuke Iida, Masahiro Abe 2021

[学会発表] Expansion of γδ T cells by CELMoDs and enhancement of their anti-myeloma effects by elotuzumab.

Takeshi Harada, Yusuke Inoue, Hirofumi Tenshin, Asuka Oda, Rhohei Sumitani, Masahiro Oura, Kimiko Sogabe, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe 2021

[学会発表] Development of combinatory treatment of Th1-like　γδ T cells with elotuzumab against osteoclasts as well as myeloma cells.

Takeshi Harada, Yusuke Inoue, Hirofumi Tenshin, Asuka Oda, Rhohei Sumitani, Masahiro Oura, Kimiko Sogabe, Shiro Fujii, Shingen Nakamura, Hirokazu Miki, Kumiko Kagawa, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe 2021

[雑誌論文] Acute Myeloid Leukemia Developing with Acute Pancreatitis Mimicking Autoimmune Pancreatitis

Sumitani Ryohei、Hori Taiki、Murai Jumpei、Kawata Shiyori、Oura Masahiro、Sogabe Kimiko、Takahashi Mamiko、Harada Takeshi、Fujii Shiro、Miki Hirokazu、Kagawa Kumiko、Abe Masahiro、Nakamura Shingen 2021

[学会発表] Resumption of myeloma cell sensitivity to proteasome inhibitors by PIM and Akt inhibition

Kimiko Sogabe, Takeshi Harada, Shingen Nakamura, Hirokazu Miki, Asuka Oda, Yusuke Inoue, Ryohei Sumitani, Tomoko Maruhashi, Masahiro Oura, Shiro Fujii, Kumiko Kagawa, Hirofumi Tenshin, Masahiro Hiasa, Jumpei Teramachi, Masahiro Abe 2021

[雑誌論文] Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement

Takahashi Mamiko、Sumitani Ryohei、Hori Taiki、Murai Jumpei、Kawata Shiyori、Oura Masahiro、Sogabe Kimiko、Harada Takeshi、Fujii Shiro、Miki Hirokazu、Kagawa Kumiko、Abe Masahiro、Nakamura Shingen 2021

[学会発表] The importance of retaining physical functions to prevent skeletal-related events in multiple myeloma patients with bone disease.

Hirokazu Miki, Shingen Nakamura, Masafumi Nakamura, Makiko Mizuguchi, Ryohei Sumitani, Masahiro Oura, Kimiko Sogabe, Mamiko Takahashi, Tomoko Maruhashi, Takeshi Harada, Shiro Fujii, Kumiko Kagawa, Hirofumi Hamano, Masateru Kondou, Naoto Okada, Yoshimi Bando, Itsuro Endo, Masahiro Abe 2021